🇺🇸 AMGN — Amgen Inc.

Healthcare Compra
← Volver

Precio actual

437,23 USD

Máx. histórico

447,03

10 días

Caída desde máximo

-2,19%

Rango 52 semanas

269,77 – 447,03

Variación hoy

-1,55%

Cierre anterior

444,12

Rango de hoy

435,01 – 441,66

Volumen hoy

1.615.172

Información
Nombre completo
Amgen Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
31.500
PER ⓘ
27,17 (puede no estar actualizado)
Dividend yield
2,27% (puede no estar actualizado)
Precio objetivo analistas
389,69 USD (puede no estar actualizado)
Primera cotización
17/06/1983
Precio actualizado
hace 2 días
Sobre la empresa

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's principal products include Enbrel for the treatment of rheumatoid arthritis, plaque psoriasis, and psoriatic arthritis; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Prolia to treat postmenopausal women with osteoporosis; XGEVA for skeletal-related events prevention; Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization; Nplate for the treatment of patients with immune thrombocytopenia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; Aranesp to treat a lower-than-normal number of red blood cells and anemia; EVENITY for the treatment of osteoporosis in postmenopausal for women; Vectibix to treat patients with wild-type RAS metastatic colorectal cancer; BLINCYTO for the treatment of patients with acute lymphoblastic leukemia; TEPEZZA to treat thyroid eye disease; and KRYSTEXXA for the treatment of chronic refractory gout. It also markets other products, including PROLIA, REPATHA, OTEZLA, ENBREL, EVENITY, XGEVA, TEPEZZA, BLINCYTO, NPLATE, TEZSPIRE, KYPROLIS, ARANESP, KRYSTEXXA AND VECTIBIX, MVASI, PAVBLU, UPLIZNA, IMDELLTRA/IMDYLLTRA, AMJEVITA/AMGEVITA, TAVNEOS, NEULASTA, LUMAKRAS/LUMYKRAS, RAVICTI, PARSABIV, AIMOVIG, WEZLANA/WEZENLA, AND PROCYSBI. The company serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors. The company has collaboration agreements with AstraZeneca plc for the development and commercialization of TEZSPIRE; BEONE MEDICINES LTD. to develop and commercialize Aimovig; UCB for the development and commercialization of EVENITY; Kyowa Kirin Co., Ltd. for rocatinlimab development and commercialization; and BeiGene, Ltd. for oncology products expansion and development. The company was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Dividendos repartidos Total últimos 12 meses: 9,9400 USD · Yield: 2,27%
Fecha de pago Importe por participación
16/08/2011 0,2800 USD
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
28/02/2019 191,38 191,63 189,73 190,08 -0,70% 0,99% 2.776.200
27/02/2019 188,74 192,19 188,66 191,42 +0,70% 1,87% 1.886.200
26/02/2019 189,56 191,65 189,36 190,08 +0,14% 1,21% 2.431.000
25/02/2019 188,66 190,47 187,89 189,81 +1,23% 1,37% 3.182.600
22/02/2019 185,89 188,86 185,81 187,50 +1,08% 1,64% 2.774.100
21/02/2019 186,39 187,40 184,75 185,50 -0,76% 1,42% 2.947.600
20/02/2019 187,19 189,22 186,48 186,92 -0,03% 1,46% 3.046.400
19/02/2019 187,79 188,47 186,85 186,97 -0,73% 0,86% 2.267.500
15/02/2019 188,07 189,10 185,99 188,34 +0,89% 1,65% 3.314.600
14/02/2019 187,59 187,80 185,76 186,68 -1,22% 1,09% 2.611.500
13/02/2019 189,22 190,12 188,40 188,98 +0,29% 0,91% 2.166.000
12/02/2019 187,33 188,96 186,43 188,43 +1,42% 1,35% 2.412.400
11/02/2019 186,79 187,11 185,51 185,79 -0,11% 0,86% 2.867.300
08/02/2019 183,41 186,05 183,41 186,00 +0,96% 1,44% 2.601.000
07/02/2019 190,67 190,67 182,67 184,23 -3,42% 4,20% 4.188.100
06/02/2019 188,31 191,87 188,11 190,76 +1,30% 2,00% 3.322.400
05/02/2019 186,20 189,06 185,72 188,31 +1,14% 1,79% 4.933.300
04/02/2019 186,96 187,14 184,29 186,18 -0,48% 1,52% 2.930.900
01/02/2019 186,51 187,83 185,56 187,07 -0,02% 1,22% 2.488.900
31/01/2019 184,78 187,60 183,91 187,11 +1,22% 2,00% 4.397.900
30/01/2019 188,89 189,76 179,65 184,86 -3,77% 5,35% 8.089.100
29/01/2019 192,18 193,67 190,80 192,11 +0,08% 1,49% 3.182.100
28/01/2019 194,97 194,97 190,01 191,95 -3,43% 2,54% 4.186.200
25/01/2019 201,95 202,23 196,88 198,77 -1,09% 2,65% 4.383.600
24/01/2019 201,61 202,40 199,74 200,97 -0,29% 1,32% 2.390.800
23/01/2019 201,99 203,95 200,13 201,56 -0,21% 1,89% 1.917.500
22/01/2019 202,62 203,48 200,78 201,98 -0,93% 1,33% 3.173.100
18/01/2019 203,33 204,33 201,04 203,88 +0,97% 1,62% 3.095.000
17/01/2019 198,38 202,53 197,98 201,92 +1,52% 2,29% 2.440.200
16/01/2019 199,30 200,44 197,60 198,89 -0,25% 1,42% 3.302.400